Cover ImageSALE
市場調查報告書

脊椎用生技藥品的全球市場:2018年∼2022年

Global Spine Biologics Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361428
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
脊椎用生技藥品的全球市場:2018年∼2022年 Global Spine Biologics Market 2018-2022
出版日期: 2017年12月29日 內容資訊: 英文 109 Pages
簡介

關於脊椎用生技藥品

脊椎用生技藥品市場由於多公司的存在而分散。市場競爭非常激烈,為了保持競爭力,供應商將重點放在基於價格、品質、合規性和創新的產品上。根據產品類型,市場可以分為骨移植,BMP和BMAC。2017年,骨移植部門佔脊柱生物製劑市場的主要佔有率。同種異體移植是組織移植在具有不同基因型的個體之間的方法。廣泛用於緩解疼痛,修復肢體,改善患者生活品質等多項救命手術。

Technavio的分析師預測,從2018年到在2222年之間,全球脊椎用生技藥品市場將以4.09%的年複合成長率成長。

本報告提供全球脊椎用生技藥品市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 簡介

  • 市場概要

第5章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第6章 市場規模

  • 市場定義
  • 市場規模:2017年
  • 市場規模及預測:2017-2022年

第7章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第8章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:各產品
  • 全球骨移植市場
  • 全球BMP市場
  • 全球BMAC市場
  • 全球其他的市場
  • 市場機會:各產品

第9章 客戶形勢

第10章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 策略性聯盟的擴大
  • 腰椎融合病例的增加
  • 微創手術的採用的增加

第14章 業者情勢

  • 概要
  • 創造性破壞
  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • Alphatec Spine
  • Globus Medical
  • Medtronic
  • NuVasive

第15章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR20053

About Spine Biologics

The spine biologics market is fragmented due to the presence of several players. The market is quite competitive and to sustain the competition, the vendors are focusing on differentiating their products based on price, quality, regulatory compliance, and innovation. Based on product type the market can be segmented as Bone grafts, BMPs, and BMAC. During 2017, the bone grafts segment accounted for the major share of the spine biologics market. Allograft is the method by which tissue transplant takes place between individuals with a different genotype. It is extensively used in several life-saving procedures such as pain relief, limbs repair, and improvement of the life quality of patients.

Technavio's analysts forecast the global spine biologics market to grow at a CAGR of 4.09% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global spine biologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of spine biologics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Spine Biologics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alphatec Spine
  • Globus Medical
  • Medtronic
  • NuVasive

Other Prominent Vendors

  • AlloSource
  • AMENDIA
  • ChoiceSpine
  • DePuy Synthes
  • Exactech
  • Harvest Technologies

Market driver

  • Growing geriatric population
  • For a full, detailed list, view our report

Market trend

  • Increasing adoption of minimally invasive surgeries
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Global bone grafts market
  • Global BMPs market
  • Global BMAC market
  • Global others market
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Spine biologics market in Americas
  • Spine biologics market in EMEA
  • Spine biologics market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Growing strategic alliances
  • Increasing cases of lumbar fusion
  • Increasing adoption of minimally invasive surgery

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Alphatec Spine
  • Globus Medical
  • Medtronic
  • NuVasive

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global spine biologics market 2017
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global spine biologics market size and forecast 2017-2022 ($ millions)
  • Exhibit 09: Global spine biologics market: Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Spine biologics product market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global bone grafts market 2017-2022 ($ millions)
  • Exhibit 21: Global bone grafts market: YOY growth 2018-2022 (%)
  • Exhibit 22: Global BMPs market 2017-2022 ($ millions)
  • Exhibit 23: Global BMPs market: YoY growth 2018-2022 (%)
  • Exhibit 24: Global BMAC market 2017-2022 ($ millions)
  • Exhibit 25: Global BMAC market: YoY growth 2018-2022 (%)
  • Exhibit 26: Global others market 2017-2022 ($ millions)
  • Exhibit 27: Global others market: YoY growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Global spine biologics market share by geography 2017-2022 (%)
  • Exhibit 31: Regional comparison
  • Exhibit 32: Spine biologics market in Americas 2017-2022 ($ millions)
  • Exhibit 33: Spine biologics market in Americas: YoY growth 2018-2022 (%)
  • Exhibit 34: Top three countries in Americas
  • Exhibit 35: Spine biologics market in EMEA 2017-2022 ($ millions)
  • Exhibit 36: Spine biologics market in EMEA: YoY growth 2018-2022 (%)
  • Exhibit 37: Top three countries in EMEA
  • Exhibit 38: Spine biologics market in APAC 2017-2022 ($ millions)
  • Exhibit 39: Spine biologics market in APAC: YoY growth 2018-2022 (%)
  • Exhibit 40: Top three countries in APAC
  • Exhibit 41: Market opportunity
  • Exhibit 42: World population by age group 2015-2050 (in millions)
  • Exhibit 43: Benefits of minimally invasive technique
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Alphatec Spine: Overview
  • Exhibit 50: Alphatec Spine: Business segments
  • Exhibit 51: Alphatec Spine: Organizational developments
  • Exhibit 52: Alphatec Spine: Geographic focus
  • Exhibit 53: Alphatec Spine: Segment focus
  • Exhibit 54: Alphatec Spine: Key offerings
  • Exhibit 55: Alphatec Spine: Key customers
  • Exhibit 56: Globus Medical: Overview
  • Exhibit 57: Globus Medical: Business segments
  • Exhibit 58: Globus Medical: Organizational developments
  • Exhibit 59: Globus Medical: Geographic focus
  • Exhibit 60: Globus Medical: Segment focus
  • Exhibit 61: Globus Medical Key offerings
  • Exhibit 62: Globus Medical: Key customers
  • Exhibit 63: Medtronic: Overview
  • Exhibit 64: Medtronic: Business segments
  • Exhibit 65: Medtronic: Organizational developments
  • Exhibit 66: Medtronic: Geographic focus
  • Exhibit 67: Medtronic: Segment focus
  • Exhibit 68: Medtronic: Key offerings
  • Exhibit 69: Medtronic: Key customers
  • Exhibit 70: NuVasive: Overview
  • Exhibit 71: NuVasive: Business segments
  • Exhibit 72: NuVasive: Organizational developments
  • Exhibit 73: NuVasive: Geographic focus
  • Exhibit 74: NuVasive: Segment focus
  • Exhibit 75: NuVasive: Key offerings
  • Exhibit 76: NuVasive: Key customers
Back to Top